In this issue:
Pirfenidone in patients with IPF
The rising incidence of IPF in the UK
Viral infections in acute IPF exacerbations
BUILD-3: bosentan in IPF
6MWD in IPF: test validation and minimal clinically important difference
Marginal FVC decline predicts poor IPF outcomes
Lung compliance/DLCO reveal lung function impairment in sarcoidosis
Prognostic value of 18 F-fluorodeoxyglucose PET in pulmonary sarcoidosis
Extrapulmonary involvement in sarcoidosis
Occupational pneumoconiosis among coalminers
Please login below to download this issue (PDF)